Detalles de la búsqueda
1.
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation.
Support Care Cancer
; 30(2): 1521-1527, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34533630
2.
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
Clin Infect Dis
; 65(11): 1884-1896, 2017 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020286
3.
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 16(15): 1525-1536, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429297
4.
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry.
Biol Blood Marrow Transplant
; 19(6): 940-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23538113
5.
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
Muscle Nerve
; 43(2): 189-95, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21254083
6.
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Neurology
; 2021 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33472915
7.
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
Cytotherapy
; 12(1): 50-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19878077
8.
Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study.
Bone Marrow Transplant
; 55(11): 2114-2120, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32346078
9.
Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma.
Leuk Lymphoma
; 48(4): 759-66, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17454635
10.
Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy.
Inflamm Bowel Dis
; 10(6): 892-4, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15626911
11.
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.
Eur J Haematol
; 78(4): 330-7, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17331132
12.
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.
Blood
; 107(10): 4177-81, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16449522
13.
TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.
Blood
; 102(6): 2053-9, 2003 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12750172
Resultados
1 -
13
de 13
1
Próxima >
>>